Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Accenture
Fuji
Deloitte
Boehringer Ingelheim
US Department of Justice
McKinsey
Mallinckrodt

Generated: September 21, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Bacteriostatic Sodium Chloride 0.9% In Plastic Container

Trial ID Title Status Sponsor Phase Summary
NCT00067340 Caries Transmission Prevention in Alaska Native Infants Terminated National Institute of Dental and Craniofacial Research (NIDCR) Phase 3 The purpose of this study is to conduct a community based, randomized control trial to determine if the use of chlorhexidine mouth rinse and xylitol-sweetened chewing gum will reduce the vertical transmission of caries between Alaska Native mothers to their infants.
NCT00067340 Caries Transmission Prevention in Alaska Native Infants Terminated University of Washington Phase 3 The purpose of this study is to conduct a community based, randomized control trial to determine if the use of chlorhexidine mouth rinse and xylitol-sweetened chewing gum will reduce the vertical transmission of caries between Alaska Native mothers to their infants.
NCT00111956 Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) N/A Metabolic syndrome is associated with increased inflammatory cytokines and reduced adiponectin, that may be mediated in part by TNF production from abdominal fat. We reasoned that an anti-TNF agent would reduce C-reactive protein (CRP) and increase adiponectin, improving the inflammatory milieu associated with metabolic syndrome.
NCT00985244 Macrolide Maintenance Therapy in Chronic Obstructive Pulmonary Disease Completed Amphia Hospital N/A To assess whether maintenance treatment with macrolide antibiotics in COPD patients with three or more exacerbations in the preceding year of inclusion can decrease the exacerbation rate in the year of treatment.
NCT00985244 Macrolide Maintenance Therapy in Chronic Obstructive Pulmonary Disease Completed Erasmus Medical Center N/A To assess whether maintenance treatment with macrolide antibiotics in COPD patients with three or more exacerbations in the preceding year of inclusion can decrease the exacerbation rate in the year of treatment.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Bacteriostatic Sodium Chloride 0.9% In Plastic Container

Condition Name

Condition Name for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Intervention Trials
Metabolic Syndrome X 1
COPD 1
Pneumonia, Ventilator-Associated 1
Haemolytic and Uremic Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Intervention Trials
Syndrome 2
Bacterial Infections 1
Uterine Cervicitis 1
Pneumonia, Ventilator-Associated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Bacteriostatic Sodium Chloride 0.9% In Plastic Container

Trials by Country

Trials by Country for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Location Trials
United States 7
India 2
Netherlands 1
Italy 1
Sweden 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Location Trials
Minnesota 2
Virginia 1
Maryland 1
Illinois 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Bacteriostatic Sodium Chloride 0.9% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Clinical Trial Phase Trials
Phase 4 8
Phase 3 2
Phase 2 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Clinical Trial Phase Trials
Completed 8
Unknown status 5
Recruiting 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Bacteriostatic Sodium Chloride 0.9% In Plastic Container

Sponsor Name

Sponsor Name for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Sponsor Trials
University of Rome Tor Vergata 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1
Statens Serum Institut 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Sponsor Trials
Other 24
Industry 4
NIH 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
Baxter
Boehringer Ingelheim
Citi
Medtronic
Merck
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.